Search Results for "Actemra"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Actemra. Results 21 to 23 of 23 total matches.
See also: tocilizumab

Ciltacabtagene Autoleucel (Carvykti) for Multiple Myeloma (online only)

   
The Medical Letter on Drugs and Therapeutics • Nov 14, 2022  (Issue 1663)
has been successfully treated with the IL-6 receptor antagonist tocilizumab (Actemra), with or without corticosteroids ...
The FDA has approved ciltacabtagene autoleucel (Carvykti – Janssen), a B-cell maturation antigen (BCMA)-directed genetically-modified cellular product, for treatment of relapsed or refractory multiple myeloma in adults who received ≥4 prior lines of therapy, including a proteasome inhibitor, an immunomodulatory drug, and an anti-CD38 monoclonal antibody. Carvykti is an individualized cellular product prepared from the patient's own T cells, which are genetically modified to express chimeric antigen receptors (CAR) and then infused back into the patient. Idecabtagene...
Med Lett Drugs Ther. 2022 Nov 14;64(1663):e188-9 |  Show IntroductionHide Introduction

Some Drugs for COVID-19

   
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020  (Issue 1595)
, such as tocilizumab (Actemra) and sarilumab (Kevzara) or JAK inhibitors, such as baricitinib (Olumiant), may mitigate ...
The severity and rapid spread of COVID-19 (caused by SARS-CoV-2) have raised questions about the use of some drugs in patients with the disease and whether currently available drugs could be effective in treating it. Definitive answers are lacking, but some recommendations can be made. For additional information on specific drugs, see our table Some Drugs Being Considered for Treatment of COVID-19.
Med Lett Drugs Ther. 2020 Apr 6;62(1595):49-50 |  Show IntroductionHide Introduction

Table: Treatments Considered for COVID-19 (Archived) (online only)

   
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020  (Issue 1595)
azithromycin ACE inhibitors acetaminophen Actemra Advil anakinra Angiotensin receptor blockers antiretrovirals ...
View the Table: Treatments Considered for COVID-19
Med Lett Drugs Ther. 2020 Apr 6;62(1595):e1-289 |  Show IntroductionHide Introduction